Skip to main content

Eva Polverino

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Eva Polverino

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Projects

Contribución de la disfunción de CFTR al desarrollo y agresividad del cáncer de páncreas. Estimulación del crecimiento tumoral y metástasis por células estrelladas carentes de CFTR.

IP: -
Collaborators: Contribución de la disfunción de CFTR al desarrollo y agresividad del cáncer de páncreas. Estimulación del crecimiento tumoral y, Eva Polverino
Funding agency: Instituto de Salud Carlos III
Funding: 147620
Reference: PI22/00887
Duration: 01/01/2023 - 31/12/2025

Grup de Recerca en Pneumologia

IP: Jaume Ferrer Sancho
Collaborators: Sergi Martí Beltran, Marta Vicenta Arjona Perís, Christian Eduardo Romero Mesones, Maria Angeles Jiménez Fuentes, María Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Álvarez Fernandez, Victor Monforte Torres, Odile Romero Santo-Tomas, Miriam Barrecheguren Fernández, David Clofent Alarcón, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Maria Antonia Ramon Belmonte, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Almudena Felipe Montiel, Eva Maria Revilla Lopez, Gerard Orriols Torras, Julia Sampol Sirvent, Meritxell Boada Perez, David Espejo Castellanos, Manuel López Meseguer, David Soler Segovia, Susana Gómez Olles, Berta Saez Gimenez, Iñigo Ojanguren Arranz, Eva Polverino
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00788
Duration: 01/01/2022 - 30/06/2025

ECRAID-Base (European Clinical Research Alliance for Infectious Diseases) H2020-SC1-2020-Single-Stage-RTD Grant agreement ID: 965313

IP: Eva Polverino
Collaborators: Monica Kruger
Funding agency: EUROPEAN COMMISSION
Funding: 21875
Reference: ECRAID-H2020-SC1-BHC-35-2020
Duration: 01/03/2021 - 28/02/2026

COVID-19, PERFIL INMUNOLÓGICO DE RIESGO

IP: -
Collaborators: Manuel Hernández González, Mónica Martínez Gallo, Moisés Labrador Horrillo, Gema Codina Grau, Albert Blanco Grau, Andres Antón Pagarolas, Antonio Álvarez Fernandez, Nuria Fernández Hidalgo, Roser Ferrer Costa, Esteve Ribera Pascuet, Juan Carlos Ruiz Rodriguez, Jaume Ferrer Sancho, Anna Suy Franch, Pere Soler Palacín, Albert Selva O'Callaghan, Tomàs Pumarola Suñé, Isabel Ruiz Camps, Daniel Alvarez De la Sierra, Andrea Martín Nalda, Eva Polverino, Romina Dieli Crimi, Romina Dieli Crimi
Funding agency: Instituto de Salud Carlos III
Funding: 229000
Reference: COV20/00416
Duration: 08/05/2020 - 08/11/2021

Related news

The meeting, the most important event in the field worldwide, took place in Barcelona from 5 to 9 September and featured presentations of more than thirty VHIR studies.

The researcher from the VHIR Pulmonology group aims to continue promoting prevention, research and respiratory health advocacy, while strengthening the international profile of research teams in Spain and Catalonia.

The study, with the participation of VHIR, will analyse the physiological response of the human body thanks to data collected by smartwatches and wearable devices.

Related professionals

Rosa Alcaraz Peñarrocha

Rosa Alcaraz Peñarrocha

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more
Monica Lucia Acevedo Castro

Monica Lucia Acevedo Castro

Research technician
Rheumatology
Read more
Vicenç Valentin Garcia

Vicenç Valentin Garcia

Gestió i Administració
Unidad de Proyectos Post-Award
Competitive Research Directorate
Read more
Andrei Iordache

Andrei Iordache

General Services and Infrastructures Unit
Infrastructure Coordination
Manager
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.